These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 12107208)

  • 1. Short-term treatment with low doses of recombinant human GH stimulates lipolysis in visceral obese men.
    Lucidi P; Parlanti N; Piccioni F; Santeusanio F; De Feo P
    J Clin Endocrinol Metab; 2002 Jul; 87(7):3105-9. PubMed ID: 12107208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A dose-response study of growth hormone (GH) replacement on whole body protein and lipid kinetics in GH-deficient adults.
    Lucidi P; Lauteri M; Laureti S; Celleno R; Santoni S; Volpi E; Angeletti G; Santeusanio F; De Feo P
    J Clin Endocrinol Metab; 1998 Feb; 83(2):353-7. PubMed ID: 9467540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating ghrelin levels of visceral obese men are not modified by a short-term treatment with very low doses of GH replacement.
    Murdolo G; Lucidi P; Di Loreto C; Parlanti N; De Cicco A; Fanelli C; Perriello G; Mughetti D; Pippi R; Brozzetti A; Santeusanio F; De Feo P
    J Endocrinol Invest; 2003 Mar; 26(3):244-9. PubMed ID: 12809175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of short-term administration of low-dose rhGH on IGF-I levels in obesity and Cushing's syndrome: indirect evaluation of sensitivity to GH.
    Maccario M; Tassone F; Gauna C; Oleandri SE; Aimaretti G; Procopio M; Grottoli S; Pflaum CD; Strasburger CJ; Ghigo E
    Eur J Endocrinol; 2001 Mar; 144(3):251-6. PubMed ID: 11248744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth hormone treatment of abdominally obese men reduces abdominal fat mass, improves glucose and lipoprotein metabolism, and reduces diastolic blood pressure.
    Johannsson G; Mårin P; Lönn L; Ottosson M; Stenlöf K; Björntorp P; Sjöström L; Bengtsson BA
    J Clin Endocrinol Metab; 1997 Mar; 82(3):727-34. PubMed ID: 9062473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two-month treatment of obese subjects with the oral growth hormone (GH) secretagogue MK-677 increases GH secretion, fat-free mass, and energy expenditure.
    Svensson J; Lönn L; Jansson JO; Murphy G; Wyss D; Krupa D; Cerchio K; Polvino W; Gertz B; Boseaus I; Sjöström L; Bengtsson BA
    J Clin Endocrinol Metab; 1998 Feb; 83(2):362-9. PubMed ID: 9467542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of recombinant human growth hormone (rhGH) supplementation on adipokines and C-reactive protein in obese subjects.
    Albert SG; Haas MJ; Mooradian AD
    Growth Horm IGF Res; 2007 Feb; 17(1):19-25. PubMed ID: 17118687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Administration of recombinant human growth hormone on alternate days is sufficient to increase whole body protein synthesis and lipolysis in growth hormone deficient adults.
    Lucidi P; Laureti S; Santoni S; Lauteri M; Busciantella-Ricci N; Angeletti G; Santeusanio F; De Feo P
    Clin Endocrinol (Oxf); 2000 Feb; 52(2):173-9. PubMed ID: 10671944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin-like growth factor I has a direct effect on glucose and protein metabolism, but no effect on lipid metabolism in type 1 diabetes.
    Simpson HL; Jackson NC; Shojaee-Moradie F; Jones RH; Russell-Jones DL; Sönksen PH; Dunger DB; Umpleby AM
    J Clin Endocrinol Metab; 2004 Jan; 89(1):425-32. PubMed ID: 14715881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose recombinant human growth hormone as adjuvant therapy to lifestyle modifications in the management of obesity.
    Albert SG; Mooradian AD
    J Clin Endocrinol Metab; 2004 Feb; 89(2):695-701. PubMed ID: 14764783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of growth hormone (GH) on glycerol and free fatty acid metabolism during exhaustive exercise in GH-deficient adults.
    Gibney J; Healy ML; Stolinski M; Bowes SB; Pentecost C; Breen L; McMillan C; Russell-Jones DL; Sonksen PH; Umpleby AM
    J Clin Endocrinol Metab; 2003 Apr; 88(4):1792-7. PubMed ID: 12679475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restoration of growth hormone (GH) response to GH-releasing hormone in elderly and obese subjects by acute pharmacological reduction of plasma free fatty acids.
    Pontiroli AE; Manzoni MF; Malighetti ME; Lanzi R
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3998-4001. PubMed ID: 8923850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leptin is suppressed during infusion of recombinant human insulin-like growth factor I (rhIGF I) in normal rats.
    Böni-Schnetzler M; Hauri C; Zapf J
    Diabetologia; 1999 Feb; 42(2):160-6. PubMed ID: 10064095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-like growth factor I and growth hormone (GH) treatment in GH-deficient humans: differential effects on protein, glucose, lipid, and calcium metabolism.
    Mauras N; O'Brien KO; Welch S; Rini A; Helgeson K; Vieira NE; Yergey AL
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1686-94. PubMed ID: 10770216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth hormone, insulin-like growth factors and their binding proteins in adult hemodialysis patients treated with recombinant human growth hormone.
    Jensen PB; Hansen TB; Frystyk J; Ladefoged SD; Pedersen FB; Christiansen JS
    Clin Nephrol; 1999 Aug; 52(2):103-9. PubMed ID: 10480221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preferential stimulation of abdominal subcutaneous lipolysis after prednisolone exposure in humans.
    Gravholt CH; Dall R; Christiansen JS; Møller N; Schmitz O
    Obes Res; 2002 Aug; 10(8):774-81. PubMed ID: 12181386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gender differences in growth hormone response to exercise before and after rhGH administration and the effect of rhGH on the hormone profile of fit normal adults.
    Giannoulis MG; Boroujerdi MA; Powrie J; Dall R; Napoli R; Ehrnborg C; Pentecost C; Cittadini A; Jørgensen JO; Sonksen PH;
    Clin Endocrinol (Oxf); 2005 Mar; 62(3):315-22. PubMed ID: 15730413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term effects of continuous subcutaneous infusion versus daily subcutaneous injections of growth hormone (GH) on the insulin-like growth factor system, insulin sensitivity, body composition, and bone and lipoprotein metabolism in GH-deficient adults.
    Laursen T; Gravholt CH; Heickendorff L; Drustrup J; Kappelgaard AM; Jørgensen JO; Christiansen JS
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1222-8. PubMed ID: 11238512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of obese, diet-restricted subjects with growth hormone for 11 weeks: effects on anabolism, lipolysis, and body composition.
    Snyder DK; Clemmons DR; Underwood LE
    J Clin Endocrinol Metab; 1988 Jul; 67(1):54-61. PubMed ID: 3379136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of long-term pharmacological antilipolysis on substrate metabolism in growth hormone (GH)-substituted GH-deficient adults.
    Nielsen S; Møller N; Pedersen SB; Christiansen JS; Jørgensen JO
    J Clin Endocrinol Metab; 2002 Jul; 87(7):3274-8. PubMed ID: 12107236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.